I blogged the other day about how a single text can often cover a range of specialist subject areas, and suggested that the whole idea of subject specialisation for translators may have been oversold.
When we are not being urged to specialise by subject area, translators are generally encouraged to find direct clients. There is usually an assumption that the two go hand in hand: that your client will be active in a particular sector and will generate texts in the associated specialist area.
But if the idea that individual texts can be categorised by subject area is often questionable, then the notion that clients will helpfully stick to their own chosen industries when producing copy strikes me as wishful thinking.
I do a lot of work for a large pharmaceutical company. This morning I’ve been despatching a batch of short texts for them. Here’s what I’ve done so far today:
- an email regarding malfunctioning public display systems
- a press release on an architectural prize
- an internal item about a professional seminar on coagulation therapy
- an internal item about a professional seminar on pharmaceutical technology
So, at least four different fields (IT, architecture, clinical medicine, medical technology) and three text types. What’s more, although all of these texts required me to decipher some technical content and identify the correct target language terminology, in every case the real challenge was more general: to work out the meaning of the source text (both technical and general) and to find the most elegant and culturally appropriate way of expressing the author’s message in English.
I sometimes worry that the focus on specialisation leads new (and not so new!) translators to assume that the biggest challenge of any text is to match the correct target language terminology with the source terms. Of course that’s important, but we shouldn’t allow it to obscure the often far more challenging ‘general’ issues of style and meaning that cut across specialisms.
The standard advice to any translator trying to move upmarket is to specialise. It obviously makes sense – you should be able to produce a better standard of work, command higher fees and build stronger relationships with your customers. However, I sometimes wonder if this advice gives the misleading impression that the translation industry (and the world) can be separated into distinct niches.
I am currently working on an expert witness opinion for a claim for damages.
But legal texts are never just legal: laws, disputes, contracts are almost always about something in the real world (the exception, I guess, are laws whose sole purpose is to regulate the legal system). In this case, the expert witness opinion is about an industrial property dispute.
So it’s industrial property.
Not so fast. This industrial property dispute is between two (groups of) pharmaceutical companies.
So it’s pharmaceuticals.
Or maybe not. Most of the details of the expert witness opinion actually relate to the financial impact of the disputed behaviour in terms of loss of earnings, impact on market share and so on.
So my legal text is actually a legal-industrial property-pharmaceuticals-corporate finance text.
The world is a messy place. And sometimes the translation industry is, too.
Translation of short article on research into the development of inhibitors in the context of treatment of haemophilia A.
Translation of short article on research into development of tests for Zika virus for use in blood banks.
Correspondence and insurance documents for a clinical trial to improve cardiovascular outcomes for patients with diabetes.
Translation of six-monthly shareholders’ report for a pharmaceuticals multinational.
Translation of verbatim responses from physicians interviewed with regard to drug treatments for lupus nephritis.
Translation of 11,000 words of verbatim responses to a survey for a new drug for the treatment of Pulmonary arterial hypertension (PAH).
Translation of correspondence regarding review and approval of clinical trials documentation (investigator brochure, protocol, informed consent etc.) for a study into pain relief for cancer patients.
Translation of articles for the in-house magazine of a pharmaceuticals multinational, including topics such as HR, business strategy and biotechnology.